Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen

The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)

NCT00002048 ·Status: COMPLETED ·Phase: NA

The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease

NCT00002324 ·Status: COMPLETED ·Phase: PHASE2

A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients

NCT00002307 ·Status: COMPLETED ·Phase: NA

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3

NCT00002161 ·Status: COMPLETED ·Phase: NA

A Randomized, Double-Blind Active-Controlled, Dose-Ranging Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients

NCT00002151 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients

NCT00002150 ·Status: COMPLETED ·Phase: PHASE2

The Safety and Effectiveness of Ribavirin in the Early Stages of HIV-Infection

NCT00002298 ·Status: TERMINATED ·Phase: NA

A Randomized Trial to Evaluate the Safety and Efficacy of Combination Therapy With Retrovir ( AZT ) and HIVID ( ddC ) Versus Retrovir, HIVID, and Wellferon ( Interferon Alfa-n1 ) for the Treatment of HIV Infection

NCT00002086 ·Status: COMPLETED ·Phase: PHASE2

Phase II Study on the Antiviral Activity and Safety of BILR 355 BS in HIV-1 Infected, NNRTI-treated Patients

NCT00294372 ·Status: TERMINATED ·Phase: PHASE2

The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks

NCT00001063 ·Status: COMPLETED ·Phase: PHASE2

Safety, Reactogenicity and Immunogenicity of HB-502 and HB-501 Versus Placebo in People With HIV on Suppressive ART

NCT06430905 ·Status: TERMINATED ·Phase: PHASE1

A Phase I Study to Evaluate the Pharmacokinetics, Safety and Antiviral Effects of Concurrent Administration of Zidovudine (AZT) and 2'3'-Dideoxyinosine (ddI) in Patients With Human Immunodeficiency Virus (HIV)

NCT00002014 ·Status: COMPLETED ·Phase: PHASE1

A Study of Retrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the Virus

NCT00002287 ·Status: COMPLETED ·Phase: NA

Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected Adults

NCT02603107 ·Status: COMPLETED ·Phase: PHASE3

Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]

NCT04564547 ·Status: COMPLETED ·Phase: PHASE2

Bioequivalency Study of Zidovudine Under Fasting Conditions

NCT00602550 ·Status: COMPLETED ·Phase: NA

A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

NCT00002369 ·Status: COMPLETED ·Phase: NA

A Study of Different Doses of Atevirdine Mesylate Plus Zidovudine in HIV-Positive Patients

NCT00002322 ·Status: COMPLETED ·Phase: PHASE2

Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients

NCT00002234 ·Status: COMPLETED ·Phase: PHASE2

Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of BILR 355 BS Plus Low Dose Ritonavir in HIV-uninfected Male Volunteers

NCT02253914 ·Status: COMPLETED ·Phase: PHASE1

A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC

NCT00002208 ·Status: COMPLETED ·Phase: PHASE3

Safety of Reduced Dose Zidovudine (AZT) Compared With Standard Dose AZT in Antiretroviral-naïve HIV-infected Patients

NCT01540240 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

The Safety and Effectiveness of Bis-POM PMEA in HIV-Infected Patients

NCT00002346 ·Status: COMPLETED ·Phase: PHASE1

DOR/ISL in HIV-1 Antiretroviral Treatment-naïve Participants (MK-8591A-053)

NCT05705349 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Bictegravir (GS-9883) in Human Immunodeficiency Virus (HIV)-1 Infected Participants

NCT02275065 ·Status: COMPLETED ·Phase: PHASE1